Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Perspectives: signal transduction. Cell survival demands some Rsk.

Literature DB >> 10610536

Perspectives: signal transduction. Cell survival demands some Rsk.

A R Nebreda¹, A C Gavin.

Abstract

Entities: Gene

Mesh：

Substances：

Year: 1999 PMID： 10610536 DOI： 10.1126/science.286.5443.1309

Source DB: PubMed Journal: Science ISSN： 0036-8075 Impact factor: 47.728

Keyword Cloud
Cited

× No keyword cloud information.

19 in total

1. ERK5 and ERK2 cooperate to regulate NF-kappaB and cell transformation.

Authors: G Pearson; J M English; M A White; M H Cobb
Journal: J Biol Chem Date: 2000-12-15 Impact factor: 5.157

2. RSK2 mediates muscle cell differentiation through regulation of NFAT3.

Authors: Yong-Yeon Cho; Ke Yao; Ann M Bode; H Robert Bergen; Benjamin J Madden; Sang-Muk Oh; Svetlana Ermakova; Bong Seok Kang; Hong Seok Choi; Jung-Hyun Shim; Zigang Dong
Journal: J Biol Chem Date: 2007-01-09 Impact factor: 5.157

3. Eriodictyol inhibits RSK2-ATF1 signaling and suppresses EGF-induced neoplastic cell transformation.

Authors: Kangdong Liu; Yong-Yeon Cho; Ke Yao; Janos Nadas; Dong Joon Kim; Eun-Jin Cho; Mee-Hyun Lee; Angelo Pugliese; Jishuai Zhang; Ann M Bode; Ziming Dong; Zigang Dong
Journal: J Biol Chem Date: 2010-11-22 Impact factor: 5.157

4. Essential role of RSK2 in c-Fos-dependent osteosarcoma development.

Authors: Jean-Pierre David; Denis Mehic; Latifa Bakiri; Arndt F Schilling; Vice Mandic; Matthias Priemel; Maria Helena Idarraga; Markus O Reschke; Oskar Hoffmann; Michael Amling; Erwin F Wagner
Journal: J Clin Invest Date: 2005-03 Impact factor: 14.808

5. Antileukemia activity of the novel peptidic CXCR4 antagonist LY2510924 as monotherapy and in combination with chemotherapy.

Authors: Byung-Sik Cho; Zhihong Zeng; Hong Mu; Zhiqiang Wang; Sergej Konoplev; Teresa McQueen; Marina Protopopova; Jorge Cortes; Joseph R Marszalek; Sheng-Bin Peng; Wencai Ma; R Eric Davis; Donald E Thornton; Michael Andreeff; Marina Konopleva
Journal: Blood Date: 2015-06-01 Impact factor: 22.113

6. Inhibition of ERK-MAP kinase signaling by RSK during Drosophila development.

Authors: Myungjin Kim; Jun Hee Lee; Hyongjong Koh; Soo Young Lee; Cholsoon Jang; Cecilia J Chung; Jung Hwan Sung; John Blenis; Jongkyeong Chung
Journal: EMBO J Date: 2006-06-08 Impact factor: 11.598

7. Targeting the leukemia microenvironment by CXCR4 inhibition overcomes resistance to kinase inhibitors and chemotherapy in AML.

Authors: Zhihong Zeng; Yue Xi Shi; Ismael J Samudio; Rui-Yu Wang; Xiaoyang Ling; Olga Frolova; Mark Levis; Joshua B Rubin; Robert R Negrin; Elihu H Estey; Sergej Konoplev; Michael Andreeff; Marina Konopleva
Journal: Blood Date: 2008-10-27 Impact factor: 22.113